Post

How to get URL link on X (Twitter) App

On the Twitter thread, click on or icon on the bottom
Click again on or Share Via icon
Click on Copy Link to Tweet
Paste it above and click "Unroll Thread"!
More info at Twitter Help

Edgar V. Lerma 🇵🇭

@edgarvlermamd

Mar 13, 2020 • 16 tweets • 22 min read • Read on X

Scrolly

Looking forward to #Nephpearls via
#Nephmadness 2️⃣🏀2️⃣🏀
👉🏼 ajkdblog.org/category/nephm…

@AJKDonline

#NephMadness 2️⃣🏀2️⃣🏀
SGLT2i Region
#Nephpearls
ajkdblog.org/2020/03/13/nep… via @AJKDonline

@AJKDonline

#NephMadness 2️⃣🏀2️⃣🏀
Vaccines Region
#Nephpearls
ajkdblog.org/2020/03/13/nep… via @AJKDonline

@NEJM

CREDENCE: Canagliflozin reduces the risk of kidney failure or death due to CV or kidney disease by 30% compared to current standard of care ca. 2019 from @NEJM
#VisualAbstract by @brendonneuen
#Nephmadness 2️⃣🏀2️⃣🏀 #Nephpearls
👉🏼 nejm.org/doi/pdf/10.105…

@NEJM

EMPA-REG: Empagliflozin, CV outcomes and mortality in Type 2 Diabetes ca. 2015 from @NEJM
#VisualAbstract by @kidney_boy
#Nephmadness 2️⃣🏀2️⃣🏀 #Nephpearls
👉🏼 nejm.org/doi/pdf/10.105…

@NEJM

CANVAS: Canagliflozin and CV & Renal events in Type 2 Diabetes ca. 2017 from @NEJM
#VisualAbstract by @kidney_boy
#Nephmadness 2️⃣🏀2️⃣🏀 #Nephpearls
👉🏼 nejm.org/doi/pdf/10.105…

@CircAHA

CV and Renal Outcomes With Canagliflozin According to Baseline Kidney Function ca. 2018 from @CircAHA
#VisualAbstract by @brendonneuen
#Nephmadness 2️⃣🏀2️⃣🏀 #Nephpearls
👉🏼 ahajournals.org/doi/pdf/10.116…

@TheLancet

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials ca. 2018 from @TheLancet
#VisualAbstract by @divyaa24
#Nephmadness 2️⃣🏀2️⃣🏀 #Nephpearls
👉🏼 ncbi.nlm.nih.gov/m/pubmed/29937…

@JASN_News

Kidney Physiology 101: Tubuloglomerular Feedback ca. 2008 from @JASN_News
#Nephmadness 2️⃣🏀2️⃣🏀 #Nephpearls
👉🏼 jasn.asnjournals.org/content/jnephr…

@KidneyNews

Indications for and pharmacologic properties of the aporoved (as of May 2019) SGLT2 inhibitors (SGLT2i) from the August 2019 issue of @KidneyNews
#Nephmadness 2️⃣🏀2️⃣🏀 #Nephpearls
👉🏼 asn-online.org/publications/k…

@KidneyNews

Ongoing Renal and CV Outcome Trials in Type 2 Diabetes from the August 2019 issue of @KidneyNews
#Nephmadness 2️⃣🏀2️⃣🏀 #Nephpearls
👉🏼 asn-online.org/publications/k…

@Vernisartan

Efficacy and Safety of Empagliflozin in Kidney Transplant Recipients With Posttransplant Diabetes Mellitus ca. 2018
#VisualAbstract by @Vernisartan
#Nephmadness 2️⃣🏀2️⃣🏀 #Nephpearls
👉🏼 care.diabetesjournals.org/content/early/…

@AJKDonline

#NephMadness 2️⃣🏀2️⃣🏀
HD Access Region
#Nephpearls
ajkdblog.org/2020/03/13/nep… via @AJKDonline

@wasse_m

Patient selection, education and cannulation of percutaneous arteriovenous fistulae (pAVF) being presented by @wasse_m
#VascularAccessPearls #Nephpearls
#Nephmadness 2️⃣🏀2️⃣🏀
👉🏼 cdn.ymaws.com/www.asdin.org/…

Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) Phase III trial in patients with CKD stopped early based on overwhelming efficacy‼️
#Nephmadness 2️⃣🏀2️⃣🏀 #Nephpearls
👉🏼 Rationale and protocol academic.oup.com/ndt/article/35…

@JAMA_current

Dapagliflozin was effective at reducing cardiovascular morbidity and mortality in patients with heart failure and reduced ejection fraction independent of diabetes status ca. 2020 from @JAMA_current
#Nephmadness 2️⃣🏀2️⃣🏀 #Nephpearls
👉🏼 jamanetwork.com/journals/jama/…

• • •

Missing some Tweet in this thread? You can try to force a refresh

This Thread may be Removed Anytime!

Twitter may remove this content at anytime! Save it as PDF for later use!

More from @edgarvlermamd

Edgar V. Lerma 🇵🇭

@edgarvlermamd

Feb 26, 2022

Advancing Evidence-Based Care in Diabetes and CKD
#ISNWCN 🇲🇾 #Nephpearls

👉 kdigo.org/wp-content/upl…

Holistic approach for improving outcomes in patients with Diabetes and CKD
#ISNWCN 🇲🇾 #Nephpearls

Glucose-lowering agents in Type 2 Diabetes (T2D) and CKD: Indications and dose adjustments
#ISNWCN 🇲🇾 #Nephpearls

Read 9 tweets

Edgar V. Lerma 🇵🇭

@edgarvlermamd

Feb 26, 2022

@goKDIGO

.@goKDIGO Glomerular Diseases Guideline: Reflections on a Decade of Progress with @adrianliew8 @ReichHeather @Dr_KeishaGibson
#ISNWCN 🇲🇾 #Nephpearls

👉 kdigo.org/wp-content/upl…

@goKDIGO

IgA Nephropathy: A 1st step is in treating IgA Nephropathy is assessing "prognosis" based on data available at the time of biopsy

@goKDIGO suggest using the "prediction tool" that was derived from the largest & most geographically diverse cohort to date

#ISNWCN 🇲🇾 #Nephpearls

@goKDIGO

IgA Nephropathy: The @goKDIGO treatment algorithm recommends consideration of use of corticosteroids in patients with "persistent proteinuria >1g/day" if the risk/benefit profile is favorable

📌 A GFR of 30 is considered a threshold for treatment

#ISNWCN 🇲🇾 #Nephpearls

Read 13 tweets

Edgar V. Lerma 🇵🇭

@edgarvlermamd

Feb 23, 2022

@amjtransplant

First clinical-grade porcine 🐖 kidney xenotransplant using a human decedent model ca. 2022 from @amjtransplant #NephJC #Nephpearls

#VisualAbstract by @NamrataYParikh

👉🏼 pubmed.ncbi.nlm.nih.gov/35049121/

@ASNKidney360

Attitudes to Clinical Pig Kidney Xenotransplantation among Medical Providers and Patients ca. 2020 from @ASNKidney360 #Nephpearls

kidney360.asnjournals.org/content/1/7/657

@NEJM

Paving the Path toward Porcine Organs for Transplantation ca. 2017 from @NEJM #NephJC #Nephpearls

nejm.org/doi/full/10.10…

Read 4 tweets

Edgar V. Lerma 🇵🇭

@edgarvlermamd

Jan 30, 2022

Nephrolithiasis 101: When to order a 24-hour urine collection #Nephpearls

Multiple or metabolically active stones (stones that increase in size/ number w/in a year)

Children

Demographic groups not typically prone to stone formation

Stones other than those containing calcium

@ravineja

Interpretation of urine chemistries to identify lithogenic risk factors and assess the contribution of diet to the formation of kidney stones ca. 2016 from @ravineja #Nephpearls

sciencedirect.com/science/articl…

@CO_Neph_Hype

Neglected analytes in the 24 hour urine: ammonium and sulfate ca. 2021 from @CO_Neph_Hype @ravineja #Nephpearls

👉 pubmed.ncbi.nlm.nih.gov/34798636/

Read 4 tweets

Edgar V. Lerma 🇵🇭

@edgarvlermamd

Jan 26, 2022

@JAMAPediatrics

PREDNOS 2: Evaluation of Daily Low-Dose Prednisolone During URTI to Prevent Relapse in Children w/ Relapsing Steroid-Sensitive Nephrotic Syndrome ca, 2022 from @JAMAPediatrics #NephJC #IPNAJC #Nephpearls

#VisualAbstract by @drM_sudha

jamanetwork.com/journals/jamap…

@Ped_Neph

Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial ca. 2022 from @Ped_Neph #NephJC #IPNAJC #Nephpearls

#VisualAbstract by @md_abdulqader83

link.springer.com/article/10.100…

@bmj_latest

PREDNOS: Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome ca. 2019 from @bmj_latest #NephJC #IPNAJC #Nephpearls

#VisualAbstract by @jbda19

pubmed.ncbi.nlm.nih.gov/31156083/

Read 5 tweets

Edgar V. Lerma 🇵🇭

@edgarvlermamd

Nov 17, 2021

@goKDIGO

Clinical Practice Guideline for the Management of Glomerular Diseases ca. 2021 from @goKDIGO #NephJC #Nephpearls
#VisualGraphics by @michaelturk6

Executive Summary pubmed.ncbi.nlm.nih.gov/34556300/
Full Guideline pubmed.ncbi.nlm.nih.gov/34556256/

@neilturn

The spectrum of glomerular diseases from @neilturn #NephJC #Nephpearls

👉 global.oup.com/academic/produ…

Nephrotic range proteinuria does "not always" mean nephrotic syndrome #NephJC #Nephpearls

👉 pubmed.ncbi.nlm.nih.gov/34556256/

Read 4 tweets

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Share this page!

Enter URL or ID to Unroll

Edgar V. Lerma 🇵🇭

Try unrolling a thread yourself!

More from @edgarvlermamd

Edgar V. Lerma 🇵🇭

Edgar V. Lerma 🇵🇭

Edgar V. Lerma 🇵🇭

Edgar V. Lerma 🇵🇭

Edgar V. Lerma 🇵🇭

Edgar V. Lerma 🇵🇭

Did Thread Reader help you today?

Don't want to be a Premium member but still want to support us?

Send Email!